
The first-of-its-kind catheter-based Parachute(TM) Ventricular Partitioning Device for patients with ischemic heart failure. Clinical data from two first-in-human studies of the Parachute system show meaningful and sustained low clinical events for patients with ischemic heart failure two years following treatment with the device.